Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $29.94 billion. The enterprise value is $30.94 billion.
| Market Cap | 29.94B |
| Enterprise Value | 30.94B |
Important Dates
The last earnings date was Tuesday, February 10, 2026, before market open.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | Feb 24, 2026 |
Share Statistics
Xylem has 243.14 million shares outstanding. The number of shares has increased by 0.19% in one year.
| Current Share Class | 243.14M |
| Shares Outstanding | 243.14M |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 94.41% |
| Float | 242.54M |
Valuation Ratios
The trailing PE ratio is 31.42 and the forward PE ratio is 22.36. Xylem's PEG ratio is 1.75.
| PE Ratio | 31.42 |
| Forward PE | 22.36 |
| PS Ratio | 3.31 |
| Forward PS | 3.22 |
| PB Ratio | 2.61 |
| P/TBV Ratio | 34.18 |
| P/FCF Ratio | 34.30 |
| P/OCF Ratio | 24.13 |
| PEG Ratio | 1.75 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.34, with an EV/FCF ratio of 35.44.
| EV / Earnings | 32.33 |
| EV / Sales | 3.42 |
| EV / EBITDA | 16.34 |
| EV / EBIT | 23.46 |
| EV / FCF | 35.44 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.63 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 1.21 |
| Debt / FCF | 2.84 |
| Interest Coverage | 45.48 |
Financial Efficiency
Return on equity (ROE) is 8.40% and return on invested capital (ROIC) is 8.46%.
| Return on Equity (ROE) | 8.40% |
| Return on Assets (ROA) | 4.83% |
| Return on Invested Capital (ROIC) | 8.46% |
| Return on Capital Employed (ROCE) | 8.93% |
| Weighted Average Cost of Capital (WACC) | 9.93% |
| Revenue Per Employee | $410,682 |
| Profits Per Employee | $43,500 |
| Employee Count | 22,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 5.62 |
Taxes
In the past 12 months, Xylem has paid $231.00 million in taxes.
| Income Tax | 231.00M |
| Effective Tax Rate | 19.56% |
Stock Price Statistics
The stock price has decreased by -5.03% in the last 52 weeks. The beta is 1.17, so Xylem's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | -5.03% |
| 50-Day Moving Average | 135.62 |
| 200-Day Moving Average | 137.89 |
| Relative Strength Index (RSI) | 34.42 |
| Average Volume (20 Days) | 2,287,610 |
Short Selling Information
The latest short interest is 4.50 million, so 1.85% of the outstanding shares have been sold short.
| Short Interest | 4.50M |
| Short Previous Month | 2.83M |
| Short % of Shares Out | 1.85% |
| Short % of Float | 1.86% |
| Short Ratio (days to cover) | 2.27 |
Income Statement
In the last 12 months, Xylem had revenue of $9.04 billion and earned $957.00 million in profits. Earnings per share was $3.92.
| Revenue | 9.04B |
| Gross Profit | 3.48B |
| Operating Income | 1.32B |
| Pretax Income | 1.18B |
| Net Income | 957.00M |
| EBITDA | 1.89B |
| EBIT | 1.32B |
| Earnings Per Share (EPS) | $3.92 |
Balance Sheet
The company has $1.48 billion in cash and $2.48 billion in debt, with a net cash position of -$996.00 million or -$4.10 per share.
| Cash & Cash Equivalents | 1.48B |
| Total Debt | 2.48B |
| Net Cash | -996.00M |
| Net Cash Per Share | -$4.10 |
| Equity (Book Value) | 11.75B |
| Book Value Per Share | 47.13 |
| Working Capital | 1.79B |
Cash Flow
In the last 12 months, operating cash flow was $1.24 billion and capital expenditures -$368.00 million, giving a free cash flow of $873.00 million.
| Operating Cash Flow | 1.24B |
| Capital Expenditures | -368.00M |
| Free Cash Flow | 873.00M |
| FCF Per Share | $3.59 |
Margins
Gross margin is 38.46%, with operating and profit margins of 14.60% and 10.59%.
| Gross Margin | 38.46% |
| Operating Margin | 14.60% |
| Pretax Margin | 13.07% |
| Profit Margin | 10.59% |
| EBITDA Margin | 20.96% |
| EBIT Margin | 14.60% |
| FCF Margin | 9.66% |
Dividends & Yields
This stock pays an annual dividend of $1.72, which amounts to a dividend yield of 1.40%.
| Dividend Per Share | $1.72 |
| Dividend Yield | 1.40% |
| Dividend Growth (YoY) | 10.14% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 41.58% |
| Buyback Yield | -0.19% |
| Shareholder Yield | 1.20% |
| Earnings Yield | 3.20% |
| FCF Yield | 2.92% |
Analyst Forecast
The average price target for Xylem is $157.89, which is 28.21% higher than the current price. The consensus rating is "Buy".
| Price Target | $157.89 |
| Price Target Difference | 28.21% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 5.44% |
| EPS Growth Forecast (5Y) | 16.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.45 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.45 |
| Piotroski F-Score | 7 |